Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2019-04-08
Product name
ViraPack Transfection Kit, Part Number 200488
Emergency telephone
+(61)-290372994
Icons in SDS
Company Information
company name
Agilent Technologies Australia Pty Ltd
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
2.1 Classification of the substance or mixture
ViraPack Transfection Kit Solution 1 H319 SERIOUS EYE DAMAGE/EYE IRRITATION - Category 2A ViraPack Transfection Kit Percentage of the mixture consisting of ingredient(s) Solution 1 of unknown acute dermal toxicity: 30 - 60% Percentage of the mixture consisting of ingredient(s) of unknown acute inhalation toxicity: 30 - 60% Percentage of the mixture consisting of ingredient(s) of unknown acute oral toxicity: 30 - 60% ViraPack Transfection Kit Percentage of the mixture consisting of ingredient(s) Solution 2 of unknown acute dermal toxicity: 1 - 10% Percentage of the mixture consisting of ingredient(s) of unknown acute inhalation toxicity: 1 - 10% Percentage of the mixture consisting of ingredient(s) of unknown acute oral toxicity: 1 - 10% Virapack Transfection Kit Percentage of the mixture consisting of ingredient(s) Solution 3 of unknown acute dermal toxicity: > 60% Percentage of the mixture consisting of ingredient(s) of unknown acute inhalation toxicity: > 60% Percentage of the mixture consisting of ingredient(s) of unknown acute oral toxicity: > 60% ViraPack Transfection Kit Percentage of the mixture consisting of ingredient(s) Solution 2 of unknown hazards to the aquatic environment: 1.1% Virapack Transfection Kit Percentage of the mixture consisting of ingredient(s) Solution 3 of unknown hazards to the aquatic environment: 98.8%
Hazard pictograms
ViraPack Transfection Kit Solution 1
Signal word
ViraPack Transfection Kit WARNING Solution 1 ViraPack Transfection Kit No signal word. Solution 2 Virapack Transfection Kit No signal word. Solution 3 pCMV ß-Gal Control Plasmid No signal word.
Hazard statements
ViraPack Transfection Kit H319 - Causes serious eye irritation. Solution 1 ViraPack Transfection Kit No known significant effects or critical hazards. Solution 2 Virapack Transfection Kit No known significant effects or critical hazards. Solution 3 pCMV ß-Gal Control Plasmid No known significant effects or critical hazards.
Prevention
ViraPack Transfection Kit P280 - Wear eye or face protection. Solution 1 P264 - Wash hands thoroughly after handling. ViraPack Transfection Kit Not applicable. Solution 2 Virapack Transfection Kit Not applicable. Solution 3 pCMV ß-Gal Control Plasmid Not applicable.
Response
ViraPack Transfection Kit P305 + P351 + P338 - IF IN EYES: Rinse cautiously Solution 1 with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical attention. ViraPack Transfection Kit Not applicable. Solution 2 Virapack Transfection Kit Not applicable. Solution 3 pCMV ß-Gal Control Plasmid Not applicable.
Storage
ViraPack Transfection Kit Not applicable. Solution 1 ViraPack Transfection Kit Not applicable. Solution 2 Virapack Transfection Kit Not applicable. Solution 3 pCMV ß-Gal Control Plasmid Not applicable.
Disposal
ViraPack Transfection Kit Not applicable. Solution 1 ViraPack Transfection Kit Not applicable. Solution 2 Virapack Transfection Kit Not applicable. Solution 3 pCMV ß-Gal Control Plasmid Not applicable.
Supplemental label elements
elements Additional warning : ViraPack Transfection Kit Not applicable. phrases Solution 1 ViraPack Transfection Kit Not applicable. Solution 2 Virapack Transfection Kit Not applicable. Solution 3 pCMV ß-Gal Control Plasmid Not applicable. Other hazards which do not : ViraPack Transfection Kit None known. result in classification Solution 1 ViraPack Transfection Kit None known. Solution 2 Virapack Transfection Kit None known. Solution 3 pCMV ß-Gal Control Plasmid None known.
